Association  ||| S:0 E:12 ||| NNP
of  ||| S:12 E:15 ||| IN
cardiorespiratory  ||| S:15 E:33 ||| JJ
fitness  ||| S:33 E:41 ||| NN
with  ||| S:41 E:46 ||| IN
pressure  ||| S:46 E:55 ||| NN
pain  ||| S:55 E:60 ||| NN
sensitivity  ||| S:60 E:72 ||| NN
and  ||| S:72 E:76 ||| CC
clinical  ||| S:76 E:85 ||| JJ
pain  ||| S:85 E:90 ||| NN
in  ||| S:90 E:93 ||| IN
women  ||| S:93 E:99 ||| NNS
with  ||| S:99 E:104 ||| IN
fibromyalgia  ||| S:104 E:117 ||| VBG
The  ||| S:117 E:121 ||| DT
aim  ||| S:121 E:125 ||| NN
of  ||| S:125 E:128 ||| IN
the  ||| S:128 E:132 ||| DT
present  ||| S:132 E:140 ||| JJ
study  ||| S:140 E:146 ||| NN
was  ||| S:146 E:150 ||| VBD
to  ||| S:150 E:153 ||| TO
assess  ||| S:153 E:160 ||| VB
the  ||| S:160 E:164 ||| DT
association  ||| S:164 E:176 ||| NN
of  ||| S:176 E:179 ||| IN
cardiorespiratory  ||| S:179 E:197 ||| JJ
fitness  ||| S:197 E:205 ||| NN
( ||| S:205 E:206 ||| -LRB-
CRF ||| S:206 E:209 ||| NNP
)  ||| S:209 E:211 ||| -RRB-
with  ||| S:211 E:216 ||| IN
pressure  ||| S:216 E:225 ||| NN
pain  ||| S:225 E:230 ||| NN
sensitivity  ||| S:230 E:242 ||| NN
and  ||| S:242 E:246 ||| CC
clinical  ||| S:246 E:255 ||| JJ
pain  ||| S:255 E:260 ||| NN
in  ||| S:260 E:263 ||| IN
women  ||| S:263 E:269 ||| NNS
with  ||| S:269 E:274 ||| IN
fibromyalgia  ||| S:274 E:287 ||| NNS
( ||| S:287 E:288 ||| -LRB-
FM ||| S:288 E:290 ||| NNP
) ||| S:290 E:291 ||| -RRB-
.  ||| S:291 E:293 ||| .
Thirty-one  ||| S:293 E:304 ||| JJ
women  ||| S:304 E:310 ||| NNS
with  ||| S:310 E:315 ||| IN
FM  ||| S:315 E:318 ||| NNP
were  ||| S:318 E:323 ||| VBD
included  ||| S:323 E:332 ||| VBN
in  ||| S:332 E:335 ||| IN
the  ||| S:335 E:339 ||| DT
study ||| S:339 E:344 ||| NN
.  ||| S:344 E:346 ||| .
Pressure  ||| S:346 E:355 ||| NN
pain  ||| S:355 E:360 ||| NN
sensitivity  ||| S:360 E:372 ||| NN
was  ||| S:372 E:376 ||| VBD
assessed  ||| S:376 E:385 ||| VBN
with  ||| S:385 E:390 ||| IN
an  ||| S:390 E:393 ||| DT
electronic  ||| S:393 E:404 ||| JJ
pressure  ||| S:404 E:413 ||| NN
dolorimeter ||| S:413 E:424 ||| NN
.  ||| S:424 E:426 ||| .
The  ||| S:426 E:430 ||| DT
average  ||| S:430 E:438 ||| JJ
pressure  ||| S:438 E:447 ||| NN
pain  ||| S:447 E:452 ||| NN
threshold  ||| S:452 E:462 ||| NN
( ||| S:462 E:463 ||| -LRB-
PPT ||| S:463 E:466 ||| NNP
)  ||| S:466 E:468 ||| -RRB-
from  ||| S:468 E:473 ||| IN
the  ||| S:473 E:477 ||| DT
18  ||| S:477 E:480 ||| CD
FM-related  ||| S:480 E:491 ||| JJ
tender  ||| S:491 E:498 ||| NN
points  ||| S:498 E:505 ||| NNS
and  ||| S:505 E:509 ||| CC
the  ||| S:509 E:513 ||| DT
tender  ||| S:513 E:520 ||| NN
points  ||| S:520 E:527 ||| NNS
count  ||| S:527 E:533 ||| VBP
( ||| S:533 E:534 ||| -LRB-
TPC ||| S:534 E:537 ||| NNP
)  ||| S:537 E:539 ||| -RRB-
were  ||| S:539 E:544 ||| VBD
recorded ||| S:544 E:552 ||| VBN
.  ||| S:552 E:554 ||| .
Clinical  ||| S:554 E:563 ||| JJ
pain  ||| S:563 E:568 ||| NN
was  ||| S:568 E:572 ||| VBD
assessed  ||| S:572 E:581 ||| VBN
on  ||| S:581 E:584 ||| IN
a  ||| S:584 E:586 ||| DT
10-cm  ||| S:586 E:592 ||| JJ
visual  ||| S:592 E:599 ||| JJ
analog  ||| S:599 E:606 ||| JJ
scale  ||| S:606 E:612 ||| NN
( ||| S:612 E:613 ||| -LRB-
VAS ||| S:613 E:616 ||| NNP
;  ||| S:616 E:618 ||| :
from  ||| S:618 E:623 ||| IN
the  ||| S:623 E:627 ||| DT
FM  ||| S:627 E:630 ||| JJ
impact  ||| S:630 E:637 ||| NN
questionnaire ||| S:637 E:650 ||| NN
) ||| S:650 E:651 ||| -RRB-
.  ||| S:651 E:653 ||| .
The  ||| S:653 E:657 ||| DT
patients  ||| S:657 E:666 ||| NNS
performed  ||| S:666 E:676 ||| VBD
an  ||| S:676 E:679 ||| DT
incremental  ||| S:679 E:691 ||| JJ
treadmill  ||| S:691 E:701 ||| JJ
test ||| S:701 E:705 ||| NN
,  ||| S:705 E:707 ||| ,
which  ||| S:707 E:713 ||| WDT
consisted  ||| S:713 E:723 ||| VBD
in  ||| S:723 E:726 ||| IN
six  ||| S:726 E:730 ||| CD
increasing  ||| S:730 E:741 ||| JJ
workloads ||| S:741 E:750 ||| NN
.  ||| S:750 E:752 ||| .
Gas  ||| S:752 E:756 ||| NN
exchange  ||| S:756 E:765 ||| NN
was  ||| S:765 E:769 ||| VBD
continuously  ||| S:769 E:782 ||| RB
monitored ||| S:782 E:791 ||| VBN
,  ||| S:791 E:793 ||| ,
and  ||| S:793 E:797 ||| CC
peak  ||| S:797 E:802 ||| JJ
oxygen  ||| S:802 E:809 ||| NN
uptake  ||| S:809 E:816 ||| NNS
( ||| S:816 E:817 ||| -LRB-
as  ||| S:817 E:820 ||| IN
measure  ||| S:820 E:828 ||| NN
of  ||| S:828 E:831 ||| IN
CRF ||| S:831 E:834 ||| NNP
)  ||| S:834 E:836 ||| -RRB-
was  ||| S:836 E:840 ||| VBD
recorded ||| S:840 E:848 ||| VBN
.  ||| S:848 E:850 ||| .
Pairwise  ||| S:850 E:859 ||| JJ
correlation  ||| S:859 E:871 ||| NN
and  ||| S:871 E:875 ||| CC
multiple  ||| S:875 E:884 ||| JJ
linear  ||| S:884 E:891 ||| JJ
regression  ||| S:891 E:902 ||| NN
were  ||| S:902 E:907 ||| VBD
used  ||| S:907 E:912 ||| VBN
to  ||| S:912 E:915 ||| TO
examine  ||| S:915 E:923 ||| VB
the  ||| S:923 E:927 ||| DT
association  ||| S:927 E:939 ||| NN
of  ||| S:939 E:942 ||| IN
CRF  ||| S:942 E:946 ||| NNP
with  ||| S:946 E:951 ||| IN
PPT  ||| S:951 E:955 ||| NNP
and  ||| S:955 E:959 ||| CC
VAS ||| S:959 E:962 ||| NNP
,  ||| S:962 E:964 ||| ,
and  ||| S:964 E:968 ||| CC
binary  ||| S:968 E:975 ||| JJ
logistic  ||| S:975 E:984 ||| NNS
regression  ||| S:984 E:995 ||| VBP
assessed  ||| S:995 E:1004 ||| VBN
the  ||| S:1004 E:1008 ||| DT
odds  ||| S:1008 E:1013 ||| NNS
of  ||| S:1013 E:1016 ||| IN
having  ||| S:1016 E:1023 ||| VBG
< ||| S:1023 E:1024 ||| SYM
18  ||| S:1024 E:1027 ||| CD
positive  ||| S:1027 E:1036 ||| JJ
tender  ||| S:1036 E:1043 ||| NN
points  ||| S:1043 E:1050 ||| NNS
as  ||| S:1050 E:1053 ||| IN
a  ||| S:1053 E:1055 ||| DT
function  ||| S:1055 E:1064 ||| NN
of  ||| S:1064 E:1067 ||| IN
CRF ||| S:1067 E:1070 ||| NNP
.  ||| S:1070 E:1072 ||| .
The  ||| S:1072 E:1076 ||| DT
correlations  ||| S:1076 E:1089 ||| NN
of  ||| S:1089 E:1092 ||| IN
CRF  ||| S:1092 E:1096 ||| NNP
with  ||| S:1096 E:1101 ||| IN
the  ||| S:1101 E:1105 ||| DT
average  ||| S:1105 E:1113 ||| JJ
PPT  ||| S:1113 E:1117 ||| NNP
and  ||| S:1117 E:1121 ||| CC
VAS  ||| S:1121 E:1125 ||| NNP
were  ||| S:1125 E:1130 ||| VBD
0.355 ||| S:1130 E:1135 ||| CD
,  ||| S:1135 E:1137 ||| ,
( ||| S:1137 E:1138 ||| -LRB-
P  ||| S:1138 E:1140 ||| NNP
< ||| S:1140 E:1142 ||| SYM
0.001 ||| S:1142 E:1147 ||| NNP
)  ||| S:1147 E:1149 ||| -RRB-
and  ||| S:1149 E:1153 ||| CC
0.058  ||| S:1153 E:1159 ||| NNP
( ||| S:1159 E:1160 ||| -LRB-
P  ||| S:1160 E:1162 ||| NNP
>  ||| S:1162 E:1164 ||| CD
0.05 ||| S:1164 E:1168 ||| CD
) ||| S:1168 E:1169 ||| -RRB-
,  ||| S:1169 E:1171 ||| ,
respectively ||| S:1171 E:1183 ||| RB
.  ||| S:1183 E:1185 ||| .
Regression  ||| S:1185 E:1196 ||| JJ
analyses  ||| S:1196 E:1205 ||| NNS
revealed  ||| S:1205 E:1214 ||| VBD
that  ||| S:1214 E:1219 ||| IN
CRF  ||| S:1219 E:1223 ||| NNP
was  ||| S:1223 E:1227 ||| VBD
associated  ||| S:1227 E:1238 ||| VBN
with  ||| S:1238 E:1243 ||| IN
the  ||| S:1243 E:1247 ||| DT
PPT  ||| S:1247 E:1251 ||| NNP
( ||| S:1251 E:1252 ||| -LRB-
B  ||| S:1252 E:1254 ||| NNP
=  ||| S:1254 E:1256 ||| SYM
0.093 ||| S:1256 E:1261 ||| CD
;  ||| S:1261 E:1263 ||| :
95  ||| S:1263 E:1266 ||| CD
%  ||| S:1266 E:1268 ||| NN
CI  ||| S:1268 E:1271 ||| NNP
0.064-0.122 ||| S:1271 E:1282 ||| NNP
;  ||| S:1282 E:1284 ||| :
P  ||| S:1284 E:1286 ||| NNP
< ||| S:1286 E:1288 ||| SYM
0.001 ||| S:1288 E:1293 ||| NNP
;  ||| S:1293 E:1295 ||| :
R  ||| S:1295 E:1297 ||| NNP
( ||| S:1297 E:1298 ||| -LRB-
2 ||| S:1298 E:1299 ||| LS
)  ||| S:1299 E:1301 ||| -RRB-
=  ||| S:1301 E:1303 ||| SYM
0.306 ||| S:1303 E:1308 ||| CD
)  ||| S:1308 E:1310 ||| -RRB-
and  ||| S:1310 E:1314 ||| CC
TPC  ||| S:1314 E:1318 ||| NNP
( ||| S:1318 E:1319 ||| -LRB-
OR  ||| S:1319 E:1322 ||| NNP
1.51 ||| S:1322 E:1326 ||| CD
;  ||| S:1326 E:1328 ||| :
95  ||| S:1328 E:1331 ||| CD
%  ||| S:1331 E:1333 ||| NN
CI  ||| S:1333 E:1336 ||| NNP
1.30-1.75 ||| S:1336 E:1345 ||| NNP
;  ||| S:1345 E:1347 ||| :
P  ||| S:1347 E:1349 ||| NNP
< ||| S:1349 E:1351 ||| SYM
0.001 ||| S:1351 E:1356 ||| NNP
)  ||| S:1356 E:1358 ||| -RRB-
but  ||| S:1358 E:1362 ||| CC
not  ||| S:1362 E:1366 ||| RB
with  ||| S:1366 E:1371 ||| IN
VAS  ||| S:1371 E:1375 ||| NNP
( ||| S:1375 E:1376 ||| -LRB-
B  ||| S:1376 E:1378 ||| NNP
=  ||| S:1378 E:1380 ||| SYM
0.068 ||| S:1380 E:1385 ||| CD
;  ||| S:1385 E:1387 ||| :
95  ||| S:1387 E:1390 ||| CD
%  ||| S:1390 E:1392 ||| NN
CI  ||| S:1392 E:1395 ||| NNP
-0.061-0.197 ||| S:1395 E:1407 ||| NNP
;  ||| S:1407 E:1409 ||| :
P  ||| S:1409 E:1411 ||| NN
>  ||| S:1411 E:1413 ||| CD
0.05 ||| S:1413 E:1417 ||| CD
) ||| S:1417 E:1418 ||| -RRB-
.  ||| S:1418 E:1420 ||| .
The  ||| S:1420 E:1424 ||| DT
findings  ||| S:1424 E:1433 ||| NNS
of  ||| S:1433 E:1436 ||| IN
this  ||| S:1436 E:1441 ||| DT
study  ||| S:1441 E:1447 ||| NN
suggest  ||| S:1447 E:1455 ||| VBP
that  ||| S:1455 E:1460 ||| IN
CRF  ||| S:1460 E:1464 ||| NNP
is  ||| S:1464 E:1467 ||| VBZ
associated  ||| S:1467 E:1478 ||| VBN
with  ||| S:1478 E:1483 ||| IN
pressure  ||| S:1483 E:1492 ||| NN
pain  ||| S:1492 E:1497 ||| NN
sensitivity  ||| S:1497 E:1509 ||| NN
but  ||| S:1509 E:1513 ||| CC
not  ||| S:1513 E:1517 ||| RB
with  ||| S:1517 E:1522 ||| IN
clinical  ||| S:1522 E:1531 ||| JJ
pain  ||| S:1531 E:1536 ||| NN
in  ||| S:1536 E:1539 ||| IN
women  ||| S:1539 E:1545 ||| NNS
with  ||| S:1545 E:1550 ||| IN
FM ||| S:1550 E:1552 ||| NNP
.  ||| S:1552 E:1554 ||| .
Further  ||| S:1554 E:1562 ||| JJ
longitudinal  ||| S:1562 E:1575 ||| NN
and  ||| S:1575 E:1579 ||| CC
intervention  ||| S:1579 E:1592 ||| NN
studies  ||| S:1592 E:1600 ||| NNS
are  ||| S:1600 E:1604 ||| VBP
needed  ||| S:1604 E:1611 ||| VBN
to  ||| S:1611 E:1614 ||| TO
determine  ||| S:1614 E:1624 ||| VB
whether  ||| S:1624 E:1632 ||| IN
CRF  ||| S:1632 E:1636 ||| NNP
could  ||| S:1636 E:1642 ||| MD
be  ||| S:1642 E:1645 ||| VB
involved  ||| S:1645 E:1654 ||| VBN
in  ||| S:1654 E:1657 ||| IN
some  ||| S:1657 E:1662 ||| DT
mechanisms  ||| S:1662 E:1673 ||| NNS
of  ||| S:1673 E:1676 ||| IN
pain  ||| S:1676 E:1681 ||| NN
processing ||| S:1681 E:1691 ||| NN
.  ||| S:1691 E:1693 ||| .
